Rothschild Investment LLC’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.69K Buy
261
+136
+109% +$1.9K ﹤0.01% 2311
2026
Q1
$1.18K Buy
125
+35
+39% +$384 ﹤0.01% 2800
2025
Q4
$1.12K Sell
90
-135
-60% -$1.79K ﹤0.01% 2634
2025
Q3
$3.22K Buy
225
+30
+15% +$411 ﹤0.01% 1938
2025
Q2
$2.39K Buy
195
+15
+8% +$218 ﹤0.01% 1946
2025
Q1
$3.96K Buy
180
+75
+71% +$1.76K ﹤0.01% 1546
2024
Q4
$2.38K Buy
105
+70
+200% +$1.53K ﹤0.01% 1706
2024
Q3
$636 Buy
35
+25
+250% +$579 ﹤0.01% 2402
2024
Q2
$291 Buy
+10
New +$297 ﹤0.01% 2312

Other funds holding IART

Rothschild Investment LLC's IART Position: Q2 2026 in Review

Rothschild Investment LLC increased its Integra LifeSciences (IART) stake by 109% in Q2 2026, buying an estimated $1.9K and bringing the position to 261 shares worth $4.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2311.

Rothschild Investment LLC first reported a position in IART in Q2 2024 and has held it in 9 quarters since. 78 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Rothschild Investment LLC held 261 shares of Integra LifeSciences worth $4.69K as of Q2 2026.
  • Rothschild Investment LLC bought 136 Integra LifeSciences shares in Q2 2026, an estimated $1.9K.
  • Integra LifeSciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2311 holding.
  • Rothschild Investment LLC first reported a position in Integra LifeSciences in Q2 2024 and has held it in 9 quarters since.
  • 78 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.